|
1
|
Estey E and Döhner H: Acute myeloid
leukaemia. Lancet. 368:1894–1907. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Smith M, Barnett M, Bassan R, Gatta G,
Tondini C and Kern W: Adult acute myeloid leukaemia. Crit Rev Oncol
Hematol. 50:197–222. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lowenberg B, Downing JR and Burnett A:
Acute myeloid leukemia. N Engl J Med. 341:1051–1062. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tallman MS, Gilliland DG and Rowe JM: Drug
therapy for acute myeloid leukemia. Blood. 106:1154–1163. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ferrara F: Unanswered questions in acute
myeloid leukaemia. Lancet Oncol. 5:443–450. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Look AT: Oncogenic transcription factors
in the human acute leukemias. Science. 278:1059–1064. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Castilla LH, Garrett L, Adya N, Orlic D,
Dutra A, Anderson S, Owens J, Eckhaus M, Bodine D and Liu PP: The
fusion gene Cbfb-MYH11 blocks myeloid differentiation and
predisposes mice to acute myelomonocytic leukaemia. Nat Genet.
23:144–146. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Falini B, Nicoletti I, Martelli MF and
Mecucci C: Acute myeloid leukemia carrying cytoplasmic/mutated
nucleophosmin (NPMc+ AML): Biologic and clinical features. Blood.
109:874–885. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Christiansen DH, Andersen MK, Desta F and
Pedersen-Bjergaard J: Mutations of genes in the receptor tyrosine
kinase (RTK)/RAS-BRAF signal transduction pathway in
therapy-related myelodysplasia and acute myeloid leukemia.
Leukemia. 19:2232–2240. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feng L, Xie X, Ding Q, Luo X, He J, Fan F,
Liu W, Wang Z and Chen Y: Spatial regulation of Raf kinase
signaling by RKTG. Proc Natl Acad Sci USA. 104:pp. 14348–14353.
2007; View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fan F, Feng L, He J, Wang X, Jiang X,
Zhang Y, Wang Z and Chen Y: RKTG sequesters B-Raf to the Golgi
apparatus and inhibits the proliferation and tumorigenicity of
human malignant melanoma cells. Carcinogenesis. 29:1157–1163. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cano E and Mahadevan LC: Parallel signal
processing among mammalian MAPKs. Trends Biochem Sci. 20:117–122.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Y, Jiang X, Qin X, Ye D, Yi Z, Liu
M, Bai O, Liu W, Xie X, Wang Z, et al: RKTG inhibits angiogenesis
by suppressing MAPK-mediated autocrine VEGF signaling and is
downregulated in clear-cell renal cell carcinoma. Oncogene.
29:5404–5415. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang X, Li X, Fan F, Jiao S, Wang L, Zhu
L, Pan Y, Wu G, Ling ZQ, Fang J and Chen Y: PAQR3 plays a
suppressive role in the tumorigenesis of colorectal cancers.
Carcinogenesis. 33:2228–2235. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu Q, Zhuang K and Li H: PAQR3 plays a
suppressive role in laryngeal squamous cell carcinoma. Tumour Biol.
37:561–565. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma Z, Wang Y, Piao T, Li Z, Zhang H, Liu Z
and Liu J: The tumor suppressor role of PAQR3 in osteosarcoma.
Tumour Biol. 36:3319–3324. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ling ZQ, Guo W, Lu XX, Zhu X, Hong LL,
Wang Z, Wang Z and Chen Y: A Golgi-specific protein PAQR3 is
closely associated with the progression, metastasis and prognosis
of human gastric cancers. Ann Oncol. 25:1363–1372. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xie X, Zhang Y, Jiang Y, Liu W, Ma H, Wang
Z and Chen Y: Suppressive function of RKTG on chemical
carcinogen-induced skin carcinogenesis in mouse. Carcinogenesis.
29:1632–1638. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Porter AG and Jänicke RU: Emerging roles
of caspase-3 in apoptosis. Cell Death Differ. 6:99–104. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Oltvai ZN, Milliman CL and Korsmeyer SJ:
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that
accelerates programmed cell death. Cell. 74:609–619. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Marshall CJ: Specificity of receptor
tyrosine kinase signaling: Transient versus sustained extracellular
signal-regulated kinase activation. Cell. 80:179–185. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao S, Konopleva M, Cabreira-Hansen M,
Xie Z, Hu W, Milella M, Estrov Z, Mills GB and Andreeff M:
Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD
and promotes apoptosis in myeloid leukemias. Leukemia. 18:267–275.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gregorj C, Ricciardi MR, Petrucci MT,
Scerpa MC, De Cave F, Fazi P, Vignetti M, Vitale A, Mancini M,
Cimino G, et al: ERK1/2 phosphorylation is an independent predictor
of complete remission in newly diagnosed adult acute lymphoblastic
leukemia. Blood. 109:5473–5476. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Milella M, Konopleva M, Precupanu CM, Tabe
Y, Ricciardi MR, Gregorj C, Collins SJ, Carter BZ, D'Angelo C,
Petrucci MT, et al: MEK blockade converts AML differentiating
response to retinoids into extensive apoptosis. Blood.
109:2121–2129. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Milella M, Kornblau SM, Estrov Z, Carter
BZ, Lapillonne H, Harris D, Konopleva M, Zhao S, Estey E and
Andreeff M: Therapeutic targeting of the MEK/MAPK signal
transduction module in acute myeloid leukemia. J Clin Invest.
108:851–859. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jiang Y, Xie X, Zhang Y, Luo X, Wang X,
Fan F, Zheng D, Wang Z and Chen Y: Regulation of G-protein
signaling by RKTG via sequestration of the G betagamma subunit to
the Golgi apparatus. Mol Cell Biol. 30:78–90. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu J, Wong WW, Khosravi F, Minden MD and
Penn LZ: Blocking the Raf/MEK/ERK pathway sensitizes acute
myelogenous leukemia cells to lovastatin-induced apoptosis. Cancer
Res. 64:6461–6468. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Martelli AM, Nyakern M, Tabellini G,
Bortul R, Tazzari PL, Evangelisti C and Cocco L: Phosphoinositide
3-kinase/Akt signaling pathway and its therapeutical implications
for human acute myeloid leukemia. Leukemia. 20:911–928. 2006.
View Article : Google Scholar : PubMed/NCBI
|
